Perrigo (PRGO) Competitors

Perrigo (NYSE:PRGO) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.

Do analysts recommend PRGO or JAZZ?

Perrigo currently has a consensus target price of $35.00, suggesting a potential upside of 39.54%. Jazz Pharmaceuticals has a consensus target price of $177.00, suggesting a potential upside of 45.52%. Given Jazz Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Jazz Pharmaceuticals is more favorable than Perrigo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perrigo	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Jazz Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.87

Do institutionals and insiders hold more shares of PRGO or JAZZ?

95.9% of Perrigo shares are held by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are held by institutional investors. 0.4% of Perrigo shares are held by insiders. Comparatively, 4.2% of Jazz Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has stronger valuation and earnings, PRGO or JAZZ?

Jazz Pharmaceuticals has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perrigo	$4.66B	0.74	-$12.70M	-$1.17	-21.44
Jazz Pharmaceuticals	$3.83B	1.92	$414.83M	$7.10	17.13

Which has more volatility & risk, PRGO or JAZZ?

Perrigo has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500.

Does the media favor PRGO or JAZZ?

In the previous week, Perrigo had 2 more articles in the media than Jazz Pharmaceuticals. MarketBeat recorded 11 mentions for Perrigo and 9 mentions for Jazz Pharmaceuticals. Jazz Pharmaceuticals' average media sentiment score of 1.24 beat Perrigo's score of 0.62 indicating that Jazz Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Perrigo	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jazz Pharmaceuticals	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in PRGO or JAZZ?

Jazz Pharmaceuticals received 355 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 80.76% of users gave Jazz Pharmaceuticals an outperform vote while only 66.38% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Perrigo	Outperform Votes 770 66.38%	Underperform Votes 390 33.62%
Jazz Pharmaceuticals	Outperform Votes 1125 80.76%	Underperform Votes 268 19.24%

Is PRGO or JAZZ more profitable?

Jazz Pharmaceuticals has a net margin of 11.60% compared to Perrigo's net margin of -3.64%. Jazz Pharmaceuticals' return on equity of 29.30% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perrigo	-3.64%	7.38%	3.18%
Jazz Pharmaceuticals	11.60%	29.30%	9.72%

Summary

Jazz Pharmaceuticals beats Perrigo on 15 of the 18 factors compared between the two stocks.